5 unchanged sentences
In February 2016, we announced the establishment of a dividend policy and the declaration by our Board of Directors of an initial quarterly cash dividend in the amount of $0.04 per share of our issued and outstanding common stock.
−Removed: Beginning in 2022, we increased the quarterly cash dividend to our shareholders in the amount of $0.05 per share of our issued and outstanding common stock and in February 2024 announced that our Board had approved a quarterly dividend for the first quarter of 2024 of $0.05 per share, payable in March.
+Added: Beginning in 2022, we increased the quarterly cash dividend to our shareholders in the amount of $0.05 per share of our issued and outstanding common stock.
+Added: In February 2025, we announced that our Board had approved a quarterly dividend for the first quarter of 2025 of $0.05 per share, payable in March.
Future dividend payments, if any, are subject to approval of our Board of Directors.
Stock Price Performance Graph
−Removed: The graph below compares Bruker Corporation’s annual percentage change in cumulative total return on common shares over the past five years with the cumulative total return of companies comprising the Nasdaq US Benchmark TR Index and the SIC Code 3826 Laboratory Analytical Instruments Index.
+Added: The graph below compares Bruker Corporation’s annual percentage change in cumulative total return on common shares over the past five years ended December 31, 2024 with the cumulative total return of companies comprising the Nasdaq US Benchmark TR Index and the SIC Code 3826 Laboratory Analytical Instruments Index.
This presentation assumes that $100 was invested in shares of the relevant issuers on December 31, 2019, and that dividends received were immediately invested in additional shares.
7 unchanged sentences
Issuer Purchases of Securities
−Removed: The following table provides information about purchases made by or on behalf of the Company or any “affiliated purchaser,” as defined in Rule 10b-18(a)(3) under the Exchange Act, during the quarter ended December 31, 2023, of shares of our common stock.
−Removed: Total Number of
−Removed: Shares Purchased
−Removed: Average Price
−Removed: Paid per Share
−Removed: Total Number of
−Removed: Shares Purchased as
−Removed: Part of Publicly
−Removed: Announced Plans or
−Removed: Maximum Number (or
−Removed: Approximate Dollar Value) of
−Removed: Shares that May Yet Be
−Removed: Purchased Under the Plans
−Removed: or Programs (2)
−Removed: October 1—October 31, 2023
−Removed: November 1—November 30, 2023
−Removed: December 1—December 31, 2023
−Removed: (1) The Company purchased shares of common stock in accordance with the 2023 share repurchase program (the “2023 Repurchase Program”).
−Removed: The shares were purchased on the open market at prevailing prices.
−Removed: Under the 2023 Repurchase Program, the Company may repurchase shares pursuant to Rule 10b5-1 and/or Rule 10b-18 under the Exchange Act.
−Removed: (2) The 2023 Repurchase Program authorizes the purchases of the Company's common stock of up to $500.0 million from time to time over a two-year period, in amounts, at prices, and at such times as management deems appropriate, subject to market conditions, legal requirements and other considerations.
−Removed: In May 2021, the Company’s Board of Directors approved a share repurchase program (the “2021 Repurchase Program”) authorizing the purchase of the Company’s common stock of up to $500.0 million, in amounts, at prices, and at such times as management deems appropriate, subject to market conditions, legal requirements and other considerations.
−Removed: We purchased a total of 4,215,094 shares at an aggregate cost of $264.7 million under the 2021 Repurchase Program during the year ended December 31, 2022.
−Removed: During the year ended December 31, 2023, we purchased a total of 315,318 shares at an aggregate cost of $22.2 million under the 2021 Repurchase Program.
−Removed: Authorization for the remaining $94.4 million on the 2021 Repurchase Program expired in May 2023.
−Removed: In May 2023, our Board of Directors approved the “2023 Repurchase Program” authorizing the purchase of up to $500.0 million of our common stock over a two-year period, in amounts, at prices, and at such times as we deem appropriate, subject to market conditions, legal requirements and other consideration.
−Removed: We purchased a total of 2,097,119 shares of common stock with an aggregate cost of approximately $130.1 million under the 2023 Repurchase Program during the year ended December 31, 2023.
−Removed: The Company currently intends to fund future share repurchases from cash on hand, future cash flows from operations and available borrowings under our revolving credit facility.
+Added: Pursuant to a share repurchase program approved by the Board of Directors and announced on May 12, 2023 (the “2023 Repurchase Program”), the Company is permitted to purchase up to $500 million of shares of its common stock over a two-year period.
+Added: As of December 31, 2024, $369.9 million remains available for future purchase under the 2023 Repurchase Program.
+Added: The Company did not make any purchases of its common stock during the year ended December 31, 2024.
ITEM 6 RESERVED
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.